Report: 2008 a robust year for biotech takeovers

05/5/2009 | Bloomberg

Biotech mergers and acquisitions had a near-record year in 2008, amounting to $28.5 billion in the U.S. alone, according to a report from Ernst & Young Global. Takeda Pharmaceutical topped the list of U.S. deals with its $8.8 billion acquisition of Millennium Pharmaceuticals. Novartis' $932 million purchase of Speedel Holding turned out to be the most expensive biotech purchase in Europe last year.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID